Cargando…

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases

Detalles Bibliográficos
Autor principal:	Wu, Baoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782537/ https://www.ncbi.nlm.nih.gov/pubmed/36569301 http://dx.doi.org/10.3389/fphar.2022.1090504

Ejemplares similares

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Editorial: Inflammation and immune diseases: Molecular targets for pathogenesis and treatment
por: Wu, Fan-Rong
Publicado: (2023)

Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets
por: Zhao, Jia, et al.
Publicado: (2023)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022)

Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain
por: Nieto, Francisco Rafael, et al.
Publicado: (2020)

Editorial: Targeting the Chemoattractant System in Inflammation
por: Hosoya, Tadashi, et al.
Publicado: (2021)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

Editorial: Targeting triple negative breast cancer by natural compounds
por: Kumar, Shashank, et al.
Publicado: (2023)

Editorial: Novel Targets and the Application of Targeting Techniques in the Treatment of Cerebrovascular Disease
por: Liu, Zhidong, et al.
Publicado: (2019)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
por: Corti, Alessandro, et al.
Publicado: (2020)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Mechanisms Underlying Diabetes-Associated Damage in Target Tissues
por: Suarez-Alvarez, Beatriz, et al.
Publicado: (2022)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Advances in inflammatory bowel disease: Mucosal defense mechanisms against gut inflammation
por: Corr, Sinéad C., et al.
Publicado: (2023)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases
por: Uddin, Md. Jamal, et al.
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: New therapeutic targets for human placental angiogenesis disease
por: Escudero, Carlos A.
Publicado: (2014)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: New Therapeutic Approaches Against Inflammation and Immune Regulation in Metabolic Related Diseases
por: Lu, Yao, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Editorial: Efficacy and mechanism of herbal medicines and their functional compounds in preventing and treating cardiovascular diseases and cardiovascular disease risk factors
por: Meng, Tiantian, et al.
Publicado: (2023)

Review on Biological Characteristics of Kv1.3 and Its Role in Liver Diseases
por: Liu, Junda, et al.
Publicado: (2021)

Editorial: Protection and healing in the digestive system and other tissues: Novel factors, mechanisms, and pharmaceutical targets
por: Brzozowski, Thomas, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Novel Targets and Biomarkers in Solid Tumors
por: Shi, Zhi, et al.
Publicado: (2019)

Editorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Egea, Javier, et al.
Publicado: (2019)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease
por: Wang, Xue-Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o1418vquimmucrk6rhp49dbuui